# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000875045-22-000003
Filing Date
2022-02-03
Accepted
2022-02-03 07:03:25
Documents
14
Period of Report
2022-02-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | biib-20220203.htm iXBRL | 8-K | 31976
2 | EX-99.1 | exhibit991-q42021pressrele.htm | EX-99.1 | 509813
6 |  | biogenlogostandarda29a.jpg | GRAPHIC | 756402
| Complete submission text file | 0000875045-22-000003.txt |  | 1741563

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | biib-20220203.xsd | EX-101.SCH | 1933
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | biib-20220203_lab.xml | EX-101.LAB | 24275
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | biib-20220203_pre.xml | EX-101.PRE | 12662
8 | EXTRACTED XBRL INSTANCE DOCUMENT | biib-20220203_htm.xml | XML | 10549

Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 22586523
SIC: 2836 Biological Products, (No Diagnostic Substances)